Podcasts about decipher

Cookies are out, context is in. People Inc.'s Jonathan Roberts joins The Big Impression to talk about how America's biggest publisher is using AI to reinvent contextual advertising with real-time intent.From Game of Thrones maps to the open web, Roberts believes content is king in the AI economy. Episode TranscriptPlease note, this transcript  may contain minor inconsistencies compared to the episode audio.Damian Fowler (00:00):I'm Damian Fowler, and welcome to this edition of The Big Impression. Today we're looking at how publishers are using AI to reinvent contextual advertising and why it's becoming an important and powerful alternative to identity-based targeting. My guest is Jonathan Roberts, chief Innovation Officer at People Inc. America's largest publisher, formerly known as Meredith. He's leading the charge with decipher an AI platform that helps advertisers reach audiences based on real time intent across all of People Inc. Site and the Open Web. We're going to break down how it works, what it means for advertisers in a privacy first world and why Jonathan's side hustle. Creating maps for Game of Thrones has something for teachers about building smarter ad tech. So let's get into it. One note, this episode was recorded before the company changed its name. After the Meredith merger, you had some challenges getting the business going again. What made you realize that sort of rethinking targeting with decipher could be the way to go?Jonathan Roberts (01:17):We had a really strong belief and always have had a strong belief in the power of great content and also great content that helps people do things. Notably and Meredith are both in the olden times, you would call them service journalism. They help people do things, they inspire people. It's not news, it's not sports. If you go to Better Homes and Gardens to understand how to refresh your living room for spring, you're going to go into purchase a lot of stuff for your living room. If you're planting seeds for a great garden, you're also going to buy garden furniture. If you're going to health.com, you're there because you're managing a condition. If you're going to all recipes, you're shopping for dinner. These are all places where the publisher and the content is a critical path on the purchase to doing something like an economically valuable something. And so putting these two businesses together to build the largest publisher in the US and one of the largest in the world was a real privilege. All combinations are hard. When we acquired Meredith, it is a big, big business. We became the largest print publisher overnight.(02:23):What we see now, because we've been growing strongly for many, many quarters, and that growth is continuing, we're public. You can see our numbers, the performance is there, the premium is there, and you can always sell anything once. The trick is will people renew when they come back? And now we're in a world where our advertising revenue, which is the majority of our digital revenue, is stable and growing, deeply reliable and just really large. And we underpin that with decipher. Decipher simply is a belief that what you're reading right now tells a lot more about who you are and what you are going to do than a cookie signal, which is two days late and not relevant. What you did yesterday is less relevant to what you need to do than what you're doing right now. And so using content as a real time predictive signal is very, very performant. It's a hundred percent addressable, right? Everyone's reading content when we target to, they're on our content and we guaranteed it would outperform cookies, and we run a huge amount of ad revenue and we've never had to pay it in a guarantee.Damian Fowler (03:34):It's interesting that you're talking about contextual, but you're talking about contextual in real time, which seems to be the difference. I mean, because some people hear contextually, they go, oh, well, that's what you used to do, place an ad next to a piece of content in the garden supplement or the lifestyle supplement, but this is different.Jonathan Roberts (03:53):Yes. Yeah. I mean, ensemble say it's 2001 called and once it's at Targeting strategy back, but all things are new again, and I think they're newly fresh and newly relevant, newly accurate because it can do things now that we were never able to do before. So one of the huge strengths of Meredith as a platform is because we own People magazine, we dominate entertainment, we have better homes and gardens and spruce, we really cover home. We have all recipes. We literally have all the recipes plus cereal, seeds plus food and wine. So we cover food. We also do tech, travel, finance and health, and you could run those as a hazard brands, and they're all great in their own, but there's no network effect. What we discovered was because I know we have a pet site and we also have real simple, and we know that if you are getting a puppy or you have an aging dog, which we know from the pet site, we know you massively over index for interest in cleaning products and cleaning ideas on real simple, right?Damian Fowler (04:55):Yeah.Jonathan Roberts (04:55):This doesn't seem like a shocking conclusion to have, but the fact that we have both tells us both, which also means that if you take a health site where we're helping people with their chronic conditions, we can see all the signals of exactly what help you need with your diet. Huge overlaps. So we have all the recipe content and we know exactly how that cross correlates with chronic conditions. We also know how those health conditions correlate into skincare because we have Brody, which deals with makeup and beauty, but also all the skincare conditions and finance, right? Health is a financial situation as much as it is a health situation, particularly in the us. And so by tying these together, because most of these situations are whole lifestyle questions, we can understand that if you're thinking about planning a cruise in the Mediterranean, you're a good target for Vanguard to market mutual funds to. Whereas if we didn't have both investipedia and travel leisure, we couldn't do that. And so there's nothing on that cruise page, on the page in the words that allows you to do keyword targeting for mutual funds.(05:55):But we're using the fact that we know that cruise is a predictor of a mutual fund purchase so that we can actually market to anyone in market per cruise. We know they've got disposable income, they're likely low risk, long-term buy andhold investors with value investing needs. And we know that because we have these assets now, we have about 1500 different topics that we track across all of DDM across 1.5 million articles, tens of millions of visits a day, billions a year. If you just look at the possible correlations between any of those taxonomies that's over a million, or if we go a level deeper, over a hundred million connected data points, you can score. We've scored all of them with billions of visits, and so we have that full map of all consumers.Damian Fowler (06:42):I wanted to ask you, of course, and you always get this question I'm sure, but you have a pretty unusual background for ad tech theoretical physics as you mentioned, and researcher at CERN and Mapmaker as well for Game of Thrones, but this isn't standard publisher experience, but how did all that scientific background play into the way you approached building this innovation?Jonathan Roberts (07:03):Yeah, I think when I first joined the company, which was a long time ago now, and one of the original bits of this company was about.com, one of the internet oh 0.1 OG sites, and there was daily data on human interest going back to January 1st, 2000 across over a thousand different topics. And in that case, tens of millions of articles. And the team said, is this useful? Is there anything here that's interesting? I was like, oh my god, you don't know what you've got because if you treat as a physicist coming in, I looked at this and was like, this is a, it's like a telescope recording all of human interest. Each piece of content is like a single pixel of your telescope. And so if somebody comes and visit, you're like, oh, I'm recording the interest of this person in this topic, and you've got this incredibly fine grained understanding of the world because you've got all these people coming to us telling us what they want every day.(08:05):If I'm a classic news publisher, I look at my data and I find out what headlines I broke, I look at my data and I learn more about my own editorial strategy than I do about the world. We do not as much tell the world what to think about. The world tells us what they care about. And so that if you treat that as just a pure experimental framework where this incredible lens into an understanding of the world, lots of things are very stable. Many questions that people ask, they always ask, but you understand why do they ask them today? What's causing the to what are the correlations between what they are understanding around our finance business through the financial crash, our health business, I ran directly through COVID. So you see this kind of real time change of the world reacting to big shocks and it allows you to predict what comes next, right? Data's lovely, but unless you can do something with it, it's useless.Damian Fowler (08:59):It's interesting to hear you talk about that consistency, the sort of predictability in some ways of, I guess intense signals or should we just say human behavior, but now we've got AI further, deeper into the mix.Jonathan Roberts (09:13):So we were the first US publisher to do a deal with open ai, and that comes in three parts. They paid for training on our content. They also agreed within the contract to source and cite our content when it was used. And the third part, the particularly interesting part, is co-development of new things. So we've been involved with them as they've been building out their search product. They've been involved with us as we've been evolving decipher, one of the pieces of decipher is saying, can I understand which content is related to which other content? And in old fashioned pre AI days when it was just machine learning and natural language processing, you would just look at words and word occurrence and important words, and you'd correlate them that way. With ai, you go from the word to the concept to the reasoning behind it to a latent understanding of these kind of deeper, deeper connections.(10:09):And so when we changed over literally like, is this content related to that content? Is this article similar in what it's treating to that article? If they didn't use the same words but they were talking about the same topic, the previous system would've missed it. This system gets deeper. It's like, oh, this is the same concept. This is the same user need. These are the same intentions. And so when we overhauled this kind of multimillion point to point connection calculation, we drastically changed about 30% of those connections and significantly improved them, gives a much reacher, much deeper understanding of our content. What we've also done is said, and this is a year thing that we launched it at the beginning of the year, we have decipher, which runs on site. We launched Decipher Plus Inventively named right? I like it. We debated Max or Max Plus, but we went with Plus.(10:59):And what this says is we understand the user intent on our sites. We know when somebody's reading content, we have a very strong predictor model of what that person's going to need to do next. And we said, well, we're not the only people with intent driven content and intent driven audiences. So we know that if you're reading about newborn health topics, you are three and a half times more likely than average to be in market for a stroller. We're not the only people that write about newborn health. So we can find the individual pages on the rest of the web that do talk about newborn health, and we can unlock that very strong prediction that this purchase intent there. And so then we can have a premium service that buy those ads and delivers that value to our clients. Now we do that mapping and we've indexed hundreds of premium domains with opening eyes vector, embedding architecture to build that logic.Damian Fowler (11:56):That's fascinating. So in lots of ways, you're helping other publishers beyond your owned and operated properties.Jonathan Roberts (12:02):We believed that there was a premium in publishing that hadn't been tapped. We proved that to be true. Our numbers support it. We bet 2.7 billion on that bet, and it worked. So we really put our money where our mouth is. We know there's a premium outside of our walls that isn't being unlocked, and we have an information advantage so we can bring more premium to the publishers who have that quality content.Damian Fowler (12:24):I've got lots of questions about that, but one of them is, alright. I guess the first one is why have publishers been so slow out of the starting blocks to get this right when on the media buying side you have all of this ad tech that's going on, DSPs, et cetera.Jonathan Roberts (12:42):I think partly it's because publishers have always been a participant in the ad tech market off to one side. I put this back to the original sin of Ad Tech, which is coming in and saying, don't worry about it, publishers, we know your audience better than you ever will. That wasn't true then, and it's not true today, but Ad Tech pivoted the market to that position and that meant the publishers were dependent upon ad Tech's understanding of their audience. Now, if you've got a cookie-based understanding of an audience, how does a publisher make that cookie-based audience more valuable? Well, they don't because you're valuing the cookie, not the real time signal. And there is no such thing as cookie targeting. It's all retargeting. All the cookie signal is yesterday Signal. It's only what they did before they came to your site, dead star like or something, right? The publisher definitionally isn't influencing the value of that cookie. So an ad tech is valuing the cookie. The only thing the publisher can do to make more money is add scale, which is either generate clickbait because that's the cheapest way to get audience scale or run more ads on the page.(13:57):Cookies as a currency for advertising and targeting is the reason we currently have the internet We deserve, not the internet we want because the incentive is to cheap scale. If instead you can prove that the content is driving the value, the content is driving the decision and the content is driving the outcome, then you invest in more premium content. If you're a publisher, the second world is the one you want. But we had a 20 year distraction from understanding the value of content. And we're only now coming back to, I think one thing I'm very really happy to see is since we launched a cipher two years ago, there are now multiple publishers coming out with similarly inspired targeting architecture or ideas about how to reach quality, which is just a sign that the market has moved, right? Or the market moving and retargeting still works. Cookies are good currency, they do drive performance. If they didn't, it would never worked in the first place. But the ability to understand and classify premium content at web scale, which is what decipher Plus is a map for all intent across the entire open web is the thing that's required for quality content to be competitive with cookies as targeting mechanism and to beat it atDamian Fowler (15:15):Scale. You mentioned how this helps you reach all these third party sites beyond your properties. How do you ensure that there's still quality in the, there's quality content that match the kind of signals that makes decipher work?Jonathan Roberts (15:32):Tell me, not all content on the internet is beautiful, clean and wonderful. Not allDamian Fowler (15:36):Premium is it?Jonathan Roberts (15:36):I know there's a lot of made for arbitrage out there. Look, we, we've been a publisher for a long time. We've acquired a lot of publishers over the years, and every time we have bought a publisher, we have had to clean up the content because cheap content for scale is a siren call of publishing. Like, oh, I can get these eyeballs cheaper. Oh, wonderful. I know I just do that. And everyone gives it on some level to that, right? So we have consistently cleaned up content libraries every time we've acquired publishers. Look at the very beginning about had maybe 10 to 15 million euros. By the time we launched these artists and these individual vertical sites were down to 250,000 pages of content. It was a bigger business and it was a better business. The other side is the actual ad layout has to be good,Damian Fowler (16:29):ButJonathan Roberts (16:29):Every time we've picked up a publisher, we've removed ads from the site. Increase, yeah, experience quality,Damian Fowler (16:33):Right?Jonathan Roberts (16:36):Because we've audited multiple publishers for the cleanup, we have an incredibly detailed understanding of what quality content is. We have lots of, this is our special skill as a publisher. We can go into a publisher, identify the content and see what's good.Damian Fowler (16:54):Is that part of your pitch as it were, to people who advertisers?Jonathan Roberts (16:58):We work lots of advertisers. We're a huge part of the advertising market because we cover all the verticals. We have endemics in every space. If you're trying to do targeting based on identity, we have tens of millions of people a day. It'll work. You will find them with us, we reach the entire country every month. We are a platform scale publisher. So at no point do we saying don't do that, obviously do that, right? But what we're saying is there's a whole bunch of people who you can't identify, either they don't have cookies or IDs or because the useful data doesn't exist yet. It's not attached to those IDs. So incremental, supplementary and additional to reach the people in the moment with a hundred percent addressability, full national reach, complete privacy compliance, just the content, total brand safety. And we will put these two things side by side and we will guarantee that the decipher targeting will outperform the cookie targeting, which isn't say don't do cookie targeting, obviously do it. It works, it's successful. This is incremental and also will outperform. And then it just depends on the client, right? Some people want brand lift and brand consideration. They want big flashy things. We run People Magazine, we host the Grammy after party. We can do all the things you need from a large partner more than just media, but also we can get you right down to, for some partners with big deals, we guarantee incremental roas,Damian Fowler (18:26):ActualJonathan Roberts (18:26):In-store sales, incremental lift.Damian Fowler (18:29):So let's talk about roas. What's driving advertisers to lean in so heavily?Jonathan Roberts (18:34):Well, I think everybody's seen this over the last couple of years. In a high interest or environment, the CMOs getting asked, what's the return on my ad spend? So whereas previously you might've just been able to do a big flashy execution or activation. Now everybody wants some level of that media spend to be attributable to lift to dollars, to return to performance, because every single person who comes through our sites is going to do something after they come. We're never the last stop in that journey, and we don't sell you those garden seeds. We do not sell you the diabetes medication directly. We are going to have to hand you off to a partner who is going to be the place you take the economic action. So we are in the path to purchase for every single purchase on Earth.(19:19):And what we've proven with decipher is not only that we can be in that pathway and put the message in the path of that person who is going to make a decision, has not made one yet. But when we put the messaging in front of it of that person at the time, it changes their decisions, which is why it's not just roas, which could just be handing out coupons in the line to the pizza store. It's incremental to us, if you did not do this, you would have made less money. When you do this, you'll make more money. And having got to a point where we've now got multiple large campaigns, both for online action and brick and mortar stores that prove that when we advertise the person at this moment, they change their decision and they make their brand more money. Turns out that's not the hardest conversation to have with marketers. Truly, truly, if you catch people at the right moment, you will change their mind.Damian Fowler (20:10):They'll happily go back to their CFO and say, look at this. This is workingJonathan Roberts (20:15):No controversially at can. During the festival of advertising that we have as a publisher, we may be the most confident to say, you know what? Advertising works.Damian Fowler (20:27):You recently brought in a dedicated president to leadJonathan Roberts (20:30):Decipher,Damian Fowler (20:30):Right? So how does that help you take what started out as this in-house innovation that you've been working on and turn it into something even bigger?Jonathan Roberts (20:39):Yeah, I think my background is physics. I was a theoretical physicist for a decade. Theoretical physicists have some good and bad traits. A good trait is a belief that everything can be solved. Because my previous job was wake up in the morning and figure out how the universe began and like, well, today I'll figure it out. And nobody else has, right? There's a level of, let's call it intellectual confidence or arrogance in that approach. How hard can it be? The answer is very, but it also means you're a little bit of a diante, right? You're coming like, oh, it's ad tech. How hard can it be? And the just vary, right? So there's a benefit. I mean, I've done a lot of work in ad tech over the last couple of years. Jim Lawson, our president of Decipher, ran a publicly listed DSP, right? He was a public company, CEO, he knows this stuff inside a and back to front, Lindsay Van Kirk on the Cipher team launched the ADN Nexus, DSP, Patrick McCarthy, who runs all of our open web and a lot of our trade desk partnerships and the execution of all of the ways we connect into the entire ecosystem.(21:38):Ran product for AppNexus. Sam Selgin on the data science team wrote that Nexus bitter. I've got a good idea where we're going with this and where we should go with this and the direction we should be pointed in. But we have seasoned multi-decade experience pros doing the work because if you don't, you can have a good idea and bad execution, then you didn't do anything. Unless you can execute to the highest level, it won't actually work. And so we've had to bring in, I'm very glad we have brought in and love having them on the team. These people who can really take the beginnings of what we have and really take this to the scale that needs to be. Decipher. Plus is a framework for understanding user intent at Webscale and getting performance for our clients and unlocking a premium at Webscale. That is a huge project to go after and pull off. We have so many case studies proving that it will work, but we have a long way to go between where we are and where this thing naturally gets to. And that takes a lot of people with a lot of professional skills to go to.Damian Fowler (22:43):What's one thing right now that you're obsessed with figuring outJonathan Roberts (22:46):To take a complete left turn, but it is the topic up and down the Cosette this summer. There isn't currently any viable model for information economy in an AI future. There's lots of ideas of what it would be, but there isn't a subtle marketplace for this. We've got a very big two-sided marketplace for information. It's called Google and search. That's obviously changing. We haven't got to a point to understand what that future is. But if AI is powered by chips, power and content, if you're a chip investor, you're in a good place. If you're investing energy, you're in a good place of the three picks and shovels investments, content is probably the most undervalued at the moment. Lots of people are starting to realize that and building under the hood what that could look like. How that evolves in the next year is going to really determine what kind of information gets created because markets align to their incentives. If you build the marketplace well, you're going to end up with great content, great journalism, great creativity. If you build it wrong, you're going to have a bunch of cheap slop getting flooded the marketplace. And we are not going to fund great journalism. So that's at a moment in time where that future is getting determined and we have a very strong set of opinions on the publishing side, what that should look like. And I am very keen to make sure it gets done. You soundDamian Fowler (24:17):Optimistic.Jonathan Roberts (24:19):A year ago, the VCs and the technologists believed if you just slammed enough information into an AI system, you'd never need content ever again. And that the brain itself was the moat. Then deep seek proved that the brain wasn't a moat. That reasoning is a commodity because we found out that China could do it cheaper and faster, and we were shocked, shocked that China could do it cheaper and faster. And then the open source community rebuilt deep to in 48 hours, which was the real killer. So if reasoning is a commodity, which it is now, then content is king, right? Because reasoning on its own is free, but if you're grounding it in quality content, your answer's better. But the market dynamics have not caught up to that reality. But that is the reality. So I am optimistic that content goes back to our premium position in this. Now we just have to do all the boring stuff of figuring out what a viable marketplace looks like, how people get paid, all of this, all the hard work, but there's now a future model to align to.Damian Fowler (25:23):I love that. Alright, I've got to ask you this question. It's the last one, but I was going to ask it. You spent time building maps, visualizing data, and I've looked at your site, it's brilliant. Is there anything from that side of your creativity that helped you think differently about building say something like decipher?Jonathan Roberts (25:42):Yeah. So I think it won't surprise anyone to find out that I'm a massive nerd, right? I used to play d and d, I still do. We have my old high school group still convenes on Sunday afternoons, and we play d and d over Discord. Fantasy maps have been an obsession of mine for a long time. I did the fantasy maps of Game of Thrones. I'm George r Martin's cartographer. I published the book Lands of Ice and Fire with him. Maps are infographics. A map is a way of taking a complex system that you cannot visualize and bringing it to a world in which you can reason about it. I spent a lot of my life taking complex systems that nobody can visualize and building models and frameworks that help people reason about 'em and make decisions in a shared way. At this moment, as you're walking up and down the cosette, there is no map for the future. Nobody has a map, nobody has a plan. Not Google, not Microsoft, not Amazon, not our friends at OpenAI. Nobody knows what's coming. And so even just getting, but lots of people have ideas and opinions and thoughts and directions. So taking all that input and rationalize again to like, okay, if we lay it out like this, what breaks? Being able to logically reason about those virtual scenario. It is exactly the same process, that mental model as Matt.Damian Fowler (27:12):And that's it for this edition of The Big Impression. This show is produced by Molten Hart. Our theme is by loving caliber, and our associate producer is Sydney Cairns. And remember,Jonathan Roberts (27:22):We do not as much tell the world what to think about. The world tells us what they care about. Data's lovely, but unless you do something with it, it's useless.Damian Fowler (27:31):I'm Damian, and we'll see you next time.

The recent decipherment of the South Arabian Dhofari script from the first millennium BCE reminds us that we don't know as much about ancient peoples and languages as we think. And finding a completely new language in a Hittite text shows that they knew a lot more than us, which is sobering, since they didn't have fancy degrees or iced pecan oat milk lattes.

We are so back! After a bit of a hiatus, we're very excited to be back with new Decipher content for you in all of the old familiar places. And also some new ones. Join Decipher editors Dennis Fisher and Lindsey O'Donnell-Welch as we start our new, independent phase, talk about what we've been up to, and discuss our plans for what fun stuff we have in store. Decipher website: https://decipher.sc/YouTube: https://www.youtube.com/@DecipherSecBluesky: https://bsky.app/profile/deciphersec.bsky.socialX: https://x.com/DecipherSec

HIFU (high-intensity focused ultrasound) is one of the most talked-about focal therapies in prostate cancer—but who is it really right for? In this conversation, Dr. Matthew Cooperberg (UCSF)—a leading voice in urology, epidemiology, and integrative prostate cancer care—breaks down patient selection vs. energy modality, how modern imaging (MRI, fusion, RSI) drives precision, what genomics (e.g., Decipher) can and can't tell us, and how salvage options compare after focal therapy vs. radiation. We also tackle lifestyle factors, trial design, and why midlife PSA screening (ideally

 (Based on Chris Lonsdale's TEDx Talk)Debunking 2 MythsYou don't need "talent."Immersion abroad isn't required."A drowning man can't learn to swim." Forced immersion without support causes stress, not fluency.The 5 Principles of Rapid Language AcquisitionRelevance is KeyFocus on content that matters to you (e.g., job, hobbies, survival phrases).Example: A chef prioritizes kitchen vocabulary over sports terms.Use It Immediately.Communicate from Day 1, like a child.Tool analogy: You master a hammer by hammering, not studying manuals.Comprehension Before PerfectionUnderstand messages first → subconscious acquisition follows."Comprehensible input" (listening/reading slightly above your level) is the engine.Physiological TrainingLanguage is muscle memory. Train your mouth/ears to recognize and produce sounds.Example: Mimic native speakers' facial movements to nail pronunciation.Psych State MattersLearn best when happy, curious, and tolerant of ambiguity.Rule: Embrace not understanding every word. Focus on what you do grasp.The 7 Actions to Fluency in 6 Months1. Brain SoakingListen to the language constantly (even passively).Absorb rhythms, patterns, and repeated phrases.2. Meaning FirstDecipher messages through context, tone, and body language (like babies do).3. Mix & CreateCombine known words creatively (*10 verbs + 10 nouns = 1,000+ phrases*).Example: Baby Okay "Me bath now" → communicates clearly despite "bad" grammar.4. Master the CoreHigh-frequency words deliver 85% coverage (1,000 words) in most languages.Week 1: Survival phrases ("What's this?", "Repeat please").Week 2: Pronouns + basics ("you," "give," "hot").Week 4: "Glue" words ("but," "though").5. Find a "Language Parent"A supportive speaker who:Understands you without correcting mistakes.Models correct language naturally.Avoid: Critical spouses/teachers.6. Copy the FaceObserve and mimic native speakers' mouth/tongue movements to perfect sounds.7. Direct ConnectionLink words to mental images/senses—not translations.Example: "Fire" → smell smoke, hear crackling, see flames.Ditch flashcards; build visceral associations.Key TakeawaysPrioritize comprehension over grammar rules.Speak immediately—perfection comes later.Learn like a child: Playful, curious, and unafraid of mistakes.Quality > quantity: 1,000 relevant words beat 5,000 random ones.Final Tip: Spend 30+ minutes daily on comprehensible input (e.g., YouTube videos, simple books) + 15 minutes speaking.Why This WorksBacked by language acquisition research (e.g., Stephen Krashen's theories).Mimics how humans learn first languages naturally.Used by polyglots and military rapid-language programs.My Video:  How to Learn Any Language in Six Months https://youtu.be/m_hgFPBnDFEMy Audio: https://divinesuccess.net/wp-content/uploads/2021/Podcast4/How-to-Learn-Any-Language-in-Six-Months.mp3

Researchers recently used near-infrared photography to get a detailed look at ancient artwork showing scenes of wild animals tangled in a fight. But these weren't paintings on a cave wall. They were tattoos on the arms of a Siberian woman who lived 2,300 years ago. What can ancient ink tell us about our ancestors? Sticking and poking their way into this with Host Flora Lichtman are archaeologist Aaron Deter-Wolf and his research collaborator, tattoo artist Danny Riday.Guests: Aaron Deter-Wolf is an archaeologist for the Tennessee Division of Archaeology in Nashville, Tennessee.Danny Riday is a tattoo artist and independent researcher based in Les Eyzies, France.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Marc from Algorand joins Sam to unpack their 2025 roadmap, the push for mainstream adoption, and lessons he brings from his time at Google and Android. He explains Algorand's unique developer-friendly features, its work on quantum security, and how AI integration will accelerate the next wave of blockchain applications.Key Timestamps[00:00] Intro & Marc's journey: from Google/Android to Algorand.[00:03] The trilemma solved? Algorand's verifiable random functions & instant finality.[00:04] Six years of uptime: reliability & scaling to real-world use cases.[00:05] The 4-pillar roadmap: values, mainstream adoption, tokenization/identity, research.[00:07] Competing with other L1s/L2s: reliability + dev-friendly built-ins.[00:09] Mainstream adoption: UX challenges, wallets, seed recovery, gas abstraction.[00:12] Balancing simplicity with self-custody & decentralization.[00:14] Algorand's “North Star” metrics for adoption & growth.[00:15] Marketing that worked: “Can a Blockchain Do That?” campaign.[00:16] AI integration: Algorand 4.0, hackathons, LLM training, agents & payments.[00:20] If Marc could remove one thing from blockchain culture → rugging.[00:21] Lessons from Google: user-first, rapid iteration, shipping daily.[00:23] Respect in Web3: why Circle stands out.[00:24] Misconceptions: people underestimate Algorand's DeFi UX.[00:25] Quantum security: state proofs, Falcon signatures, securing the ledger.[00:28] Roadmap execution: xGov community governance + ecosystem collaboration.[00:31] Hackathons, grants, accelerator/incubator funnel for startups.[00:33] Big ecosystem event: Decipher planned for 2025.Connecthttps://algorand.co/https://www.linkedin.com/company/algorandfoundation/https://x.com/AlgoFoundationhttps://www.linkedin.com/in/marcvl/DisclaimerNothing mentioned in this podcast is investment advice and please do your own research. Finally, it would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend.Be a guest on the podcast or contact us - https://www.web3pod.xyz/

An interview with Star Wars CCG 2022 content creator of the year Matt Manning. We talk about YouTube Shorts, retro Star Wars CCG, and a retro cube event that Matt helped organize.

Decipher the back of your sunscreen bottle with the help of an ecotoxicologist in Episode Two of our Greener Living series. Craig Downs helps us understand, and if we're honest, pronounce, the chemicals that have become the norm for protecting ourselves from skin cancer. But what exactly are they doing to the marine life at our favorite beaches?

Crochet, Cats & Custom GPTs: How Brianna Shade Uses AI to Scale a Handmade BusinessIn this colourful episode of Unjaded's Conscious Creation in the Age of AI summer series, Vickie Dickson chats with Brianna Shade, the creative mind behind Kitty Minis, a wildly unique brand built around geeky, handmade crochet cats and pop culture icons.Brianna shares how she turned a playful personal project into a thriving online membership, teaching fellow cat-loving crafters how to reclaim creativity, spark joy, and build community, all through the lens of crochet!But don't let the cuteness fool you: Brianna is also a former software engineer and automation strategist who now uses AI and Zapier to run her business like a boss. From custom GPTs and AI “board meetings” to automated analytics and launch planning, she breaks down exactly how she's integrating tech in a deeply human, creatively aligned way.What We Cover:How Brianna went from global traveler to crochet catpreneurThe power of building a business around fun, play, and nostalgiaWhy and how she treats AI as both assistant and business coachHow she uses ChatGPT + Zapier to track IG performance, Google Analytics, onboarding flows & moreHer non-negotiable boundary with AI and creative integrityWhy human connection can't be automated, nor should it beA refreshing take on choosing one AI platform and building with it (instead of chasing trends)It's also fun to notice how Brianna totally reveals her MG self as she talks about finding ways to be more efficient and wanting everything to go faster! You can see it in her varied career path too. “AI can't replace the human soul — but it can absolutely help you reclaim your time so you can do more of what lights you up.” – Brianna ShadeConnect with Brianna:Website: kittyminis.comInstagram: @kittenkazoedleJoin the Series:Love this convo? There's more where that came from. Catch the rest of the Conscious Creation in the Age of AI series on Unjaded and share your biggest insight with @vickie.dickson on Instagram! I love hearing from you!

Andrew Moss discusses a number of new cards centering around Mind What You Have Learned v.For full text of the spoiled cards, head over to KendallCast.NINJA

Dr. Wenqing Li joins Peng Zhang to discuss a recent study integrating genetics and transcriptomics for risk stratification of gastric cancer. The conversation explores the global epidemiology of gastric cancer, its high prevalence and mortality rates, particularly in East Asia and China, and the complex interplay of genetic and environmental risk factors, notably Helicobacter pylori infection.Read the full article:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(25)00211-7/fulltext?dgcid=buzzsprout_icw_podcast_July_25_ebiomContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

In episode 292 of The Just Checking In Podcast we checked in with Kyt Lyn Walken. Kyt is a qualified man-tracker and the Founder of her own tracking business, The Way of Tracking. Kyt's father was obsessed with western television and movies and he introduced her to man tracking skills from the age of around 5/6 years old. In 2012/2013 she got into survival skills professionally and found a school to learn how to do it. She underwent three courses in Arizona in the United States, then moved to Virginia to learn from the man who would become her tutor, before finally learning to become an instructor in 2017. After starting her own school, she saw a gap in the market and wanted to provide a bridge between forensic teams in the police and search and rescue. She created a specific programme for search and rescue teams to help put them in the mind of a missing person and what conditions they might have which would impact their behaviour i.e. autism, dementia and alzheimer's. In this episode we discuss her journey into man-tracking, becoming a qualified expert, starting her own business, the three principles of tracking she follows of ‘Identify, Decipher and Follow', as well as how the Stoics and their principles have shaped how she approaches the process of tracking. For Kyt's mental health journey, we discuss the sudden loss of her mother at the start of 2023 from a very aggressive form of cancer and the impact that had on her mental health. As always, #itsokaytovent You can find out more about The Way of Tracking here: https://thewayoftracking.com/ You can follow The Way of Tracking on social media below: Instagram: https://www.instagram.com/thewayoftracking/ You can follow Kyt on social media below: Instagram: https://www.instagram.com/kytlynwalken/ Support Us: Patreon: www.patreon.com/venthelpuk PayPal: paypal.me/freddiec1994?country.x=GB&locale.x=en_GB Merchandise: www.redbubble.com/people/VentUK/shop Music: @patawawa - Strange: www.youtube.com/watch?v=d70wfeJSEvk

Are aliens making crop circles? Visit https://rise.tv/video for free exclusive content! Visit https://metaphysicalcoffee.com for coffee that's out of this world! What happens when we use AI to decipher the symbols? Hear all about it on this Edge of Wonder Live with Ben and Rob. The world has been asking, “Where do crop circles come from?” for decades, and now researchers are using artificial intelligence to try to crack their codes. Did you know that the first reported crop circle dates all the way back to 1648 AD? While some appear to be fake, others seem to defy the very essence of physics, as many crop circles show that the crops are not just bent, but also heated in the center and interwoven in ways that make them impossible for humans to recreate. Join Ben Chasteen and Rob Counts on this Edge of Wonder live show as they search for the truth about crop circles. At the end of the show, don't miss the live Q&A followed by a meditation/prayer only on Rise.TV. See you out on the edge! Download the Rise TV iPhone app – https://apple.co/3DYB7So or Android – https://bit.ly/risetvandroid Listen on Spotify — https://spoti.fi/3z679Xn or Apple Podcasts— https://apple.co/3w0xYdM Follow Edge of Wonder for more! Telegram – https://t.me/risetvofficial Instagram – https://www.instagram.com/risetvofficial Facebook – https://www.facebook.com/risetvofficial X – https://twitter.com/risetvofficial #cropcircles #aliens #ai

Matt and Kendall discuss the second season of the Star Wars Disney Plus series.

For thousands of years, ancient cuneiform - the script of the ancient Mesopotamians was lost to time, until being dramatically rediscovered in the 19th century by an adventurous group of unlikely Victorians. A dashing archaeologist, an officer turned diplomat and a reclusive clergyman raced to decipher it and unlock the secrets of long-lost empires. Joining us is Joshua Hammer, a former war correspondent and author of 'The Mesopotamian Riddle'. Produced by Mariana Des Forges and James Hickmann, and edited by Tim Arstall.Sign up to History Hit for hundreds of hours of original documentaries, with a new release every week and ad-free podcasts. Sign up at https://www.historyhit.com/subscribe.We'd love to hear your feedback - you can take part in our podcast survey here: https://insights.historyhit.com/history-hit-podcast-always-on.You can also email the podcast directly at ds.hh@historyhit.com.

Corran's Questions is a new video series where I ask a panel of Star Wars CCG Experts some of the big questions for getting better at Star Wars CCG. In this first episode, we tackle tracking!Please note, this show is intended to watch with a video. If you have trouble following the audio only format, I recommend finding the video on Spotify or YouTube.

Join the University of Washington Surgical Palliative Care Team for their final episode of this series — a dual journal review and clinical challenges discussion on assessing medical decision-making capacity. Using Dr. Paul Applebaum's foundational framework, the team outlines the four key criteria for evaluating capacity and brings the topic to life through two contrasting standardized patient scenarios. This episode highlights why capacity assessment is not only relevant but essential for surgeons navigating complex, high-stakes decisions.  Hosts:  Dr. Katie O'Connell (@katmo15) is an associate professor of surgery at the University of Washington. She is a trauma surgeon, palliative care physician, director of surgical palliative care, and founder of the Advance Care Planning for Surgery clinic at Harborview Medical Center, Seattle, WA. Dr. Ali Haruta is an assistant professor of surgery at the University of Washington. She is a trauma and emergency general surgeon and palliative care physician. Ali recently completed fellowships in palliative care at the University of Washington and Trauma and Critical Care at Parkland.  Dr. Lindsay Dickerson (@lindsdickerson1) is a PGY6 general surgery resident at the University of Washington with an interest in surgical oncology.   Dr. Virginia Wang is a PGY3 general surgery resident at the University of Washington. Learning Objectives: 1.        Decipher the distinction between the terms “capacity” and “competence”.   2.        Describe the four criteria for assessing medical decision-making capacity presented in Dr. Paul Applebaum's article “Assessment of Patients' Competence to Consent to Treatment.” 3.        Apply the capacity assessment framework to real-world clinical scenarios in surgical practice.  References: 1.        Applebaum, PS. Assessment of Patients' Competence to Consent to Treatment. New England Journal of Medicine 2007; 357(18):1834-1840. https://pubmed.ncbi.nlm.nih.gov/17978292/ 2.        Special thank you to Mr. Mark Fox for his acting contribution to this episode. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

This week, the boys discuss The upcoming Definitive History of The DC Universe book by Mark Waid and DC's attempt to create a timeline of events for their Superhero universe. History of the DC Universe is a two-issue comic book limited series created by writer Marv Wolfman and artist George Pérez which was published by DC Comics following the end of Crisis on Infinite Earths.Like, comment, and subscribe for more content analyzing the greatest tales of DC and Marvel stories. Join this channel to get access to perks:https://www.youtube.com/channel/UCTtjdjM7N8_PLprDIdMJCWQ/join#DC#Comics#MarkWaidFollow us on instagram: comicsleague2021Email us: comicsleague2020@gmail.comWebsite: https://comicsleague.com Teladia PlaysTwitter:https://twitter.com/TeladiaPlaysYoutube:https://www.youtube.com/c/TeladiaPlaysInstagram: https://www.instagram.com/teladiaplays/Robert Willing: YouTube: https://www.youtube.com/@willin Twitter: https://twitter.com/staredcraftJJheat:Twitter:https://twitter.com/JJheat75Youtube: https://www.youtube.com/channel/UCmYlqETvh2B5pB3MbmMwoMwSubscribe to the Podcast on:Apple PodcastsGoogle PodcastsSpotifyand many other platforms.Music provided by taketones.com: https://taketones.com/track/hero

Sue and Kendra talked with Dr. Ann Burgess, a psychiatric clinical nurse and a criminal mind profiler, about the obsession with the Karen Read trial and true crime in general. Dr. Burgess is a Boston native, a professor at Boston College, author of A Killer By Design: Murderers, Mindhunters and My Quest to Decipher the Criminal Mind and the character "Wendy Carr" from the hit Netflix TV show Mindhunter was based on her.

Today on the Dr. Geo Prostate Podcast, we're joined by world-renowned oncologist Dr. Rana McKay of UC San Diego Health. With training from Harvard and Dana-Farber, Dr. McKay breaks down the evolving landscape of triplet therapy—a combination of ADT, an ARPI (androgen receptor pathway inhibitor), and chemotherapy (docetaxel)—and how it's changing survival outcomes for men with advanced prostate cancer.In this enlightening and practical episode, Dr. Geo and Dr. McKay discuss:What triplet therapy is and how it compares to doublet therapyThe latest clinical trials and the importance of timing treatmentHow to personalize care for high- and low-volume metastatic prostate cancerWhen to escalate treatment—and when quality of life may outweigh aggressive therapyThe role of genomic tools like the Decipher score in decision-makingSide effect profiles, cold therapy, fasting, and integrative strategiesWhy communication and patient values should drive treatment decisionsIf you or a loved one is facing a diagnosis of advanced prostate cancer, this episode offers invaluable clarity and hope.

Key themes include legislative efforts in the US concerning AI chip exports and regulation, industry applications of AI such as enhancing security cameras, interpreting animal sounds, and transforming creative platforms like Figma, and advancements in AI technologyitself, including new models from Google and Mistral AI, and research into autonomous agents. The text also touches on the business aspects of AI, with acquisitions, funding initiatives, and discussions around workforce impact, alongside emerging ethical and societal implications like AI's use in court and the privacy concerns surrounding advanced smart glasses.

What if everything you knew, was a trick? An elaborate scheme designed to control your thoughts, emotions, and actions? Would you be able to handle it? Decipher it? Find the puppet master without suffering a mental breakdown? These are the questions that David Fincher asks with his dark thriller, The Game (1997). A master of the thriller, Fincher keeps you on your toes until the very end. Let us know what you think. Also Play:Cinema Chain Game--------------------------------------------Subscribe, rate, and review:Apple Podcasts: Our Film FathersSpotify: Our Film FathersYouTube: Our Film Fathers---------------------------------------------Follow Us:Instagram: @ourfilmfathersTwitter / X: @ourfilmfathersEmail: ourfilmfathers@gmail.com

In this episode of the Dr. Geo Prostate Podcast, we welcome Dr. Jonathan Lischalk, Director of Genitourinary Cancers at MedStar Georgetown University Hospital and former Medical Director at NYU's NYCyberKnife Center. Dr. Lischalk breaks down the evolution of radiation oncology and how cutting-edge imaging and targeted SBRT (Stereotactic Body Radiation Therapy) are reshaping prostate cancer treatment.We explore how imaging advances like MRI and PSMA PET scans are enabling unprecedented precision, the future of genetic-based personalization in prostate cancer therapy, and why fewer, more focused radiation sessions might soon become the new standard. From understanding the biology of radiation dosing to upcoming trials eliminating ADT in select patients, this is a must-listen for anyone looking to stay informed on the forefront of cancer care.

Witness market volatility and the economic seesaw! Navigate the complexities of trade negotiations and their widespread impact. Untangle the inverse relationship between bond prices and interest rates. See how tariffs can affect prices and fuel uncertainty. Harness the power of balance and diversification to help fortify your investments. Decipher the VIX (fear index) and its historical implications for market returns. Contemplate the lessons from the 2020 market crash and recovery. Analyze the details of ongoing global trade negotiations and potential outcomes. Note the influence of consumer and business confidence amidst tariff changes. Marvel at the unchanging prices of egg salad sandwiches at the Masters Tournament and the hot dog/soda combo at Costco. Tune in to the Money Matters Podcast, hosted by Wes Moss, Jeff Lloyd, and Connor Miller, to explore securing your financial future.

THE BEST BITS IN A SILLIER PACKAGE (from Friday's Mike Hosking Breakfast) You Can't/Mark the Week/Take This Job and Love It/Coffee World ProblemsSee omnystudio.com/listener for privacy information.

On this episode, we welcome back to the program, journalist and author, Joshua Hammer who was our guest back on episode 112 in September 2016.  Joshua's career has included serving as Newsweek Bureau Chief in, Nairobi, Buenos Aires, LA, Berlin, Jerusalem and Cape Town.  His work has appeared in the New York Review of Books, The New Yorker, National Geographic and the Smithsonian just to name a few publications. He is a New York Times bestselling author of six books, including The Falcon Thief and The Bad-Ass Librarians of Timbuktu (which we talked about in our last conversation). Joshua's just released and latest book is: The Mesopotamian Riddle: An Archaeologist, a Soldier, a Clergyman, and the Race to Decipher the World's Oldest Writing, published by Simon & Schuster. In the course of the conversation we dive deep into this fascinating book – everything from the Royal Asiatic Society's 1857 Great Cuneiform Challenge and the gentlemen who took part in it, to the difficulty of the digs in the Near East, to the “Assyrian Fever” (as Joshua calls it) that swept London in 1851- 1852, to the origins of the British Museum, to the topic of cultural appropriation of a country or people's national patrimony, and more. In keeping with the theme of the show, should he take a one way ticket back in time, Joshua shared what he would tell scholars and archeologists in the mid 19th century about how their work resonates today.   As for Joshua's own one way ticket destination, it's still to Manhattan in 1967. Do check out Joshua's other books: Chosen by God: A Brother's Journey; A Season in Bethlehem: Unholy War in a Sacred Place; and Yokohama Burning: The Deadly 1923 Earthquake and Fire that Helped Forge the Path to World War II. 

Best-selling author Joshua Hammer joins John Williams to discuss his new book, “The Mesopotamian Riddle.” Joshua talks about how he finds his stories, the amount of research that went into the book, the challenge to make the story accessible, what original writing was like, how the growth of cities led to humans using script, and […]

Best-selling author Joshua Hammer joins John Williams to discuss his new book, “The Mesopotamian Riddle.” Joshua talks about how he finds his stories, the amount of research that went into the book, the challenge to make the story accessible, what original writing was like, how the growth of cities led to humans using script, and […]

Best-selling author Joshua Hammer joins John Williams to discuss his new book, “The Mesopotamian Riddle.” Joshua talks about how he finds his stories, the amount of research that went into the book, the challenge to make the story accessible, what original writing was like, how the growth of cities led to humans using script, and […]

Kendall interviews Las Vegas Retro SWCCG Event Winner Geoff Bowman about reactive decks, playing in different formats, and whether Geoff is the greatest living Retro SWCCG player..This item has files of the following types: Archive BitTorrent, Item Tile, Metadata, PNG, Spectrogram, VBR MP3

Scientists have finally cracked the code on Oumuamua's secrets! You know, that mysterious interstellar object that had everyone scratching their heads? Well, turns out, they've been working overtime to unravel its mysteries, and they've finally got some answers. It's like a cosmic detective story that's been solved after years of sleuthing. So, get ready for some mind-blowing revelations about this enigmatic visitor from beyond our solar system. It's like the universe just threw us a curveball, and scientists are here to decode it for us. #brightside Animation is created by Bright Side. ---------------------------------------------------------------------------------------- Music from TheSoul Sound: https://thesoul-sound.com/ Listen to Bright Side on: Spotify - https://open.spotify.com/show/0hUkPxD... Apple Podcast - https://podcasts.apple.com/podcast/id... ---------------------------------------------------------------------------------------- Our Social Media: Facebook - / brightside Instagram - / brightside.official Tik Tok - https://www.tiktok.com/@brightside.of... Snapchat - / 1866144599336960 Stock materials (photos, footages and other): https://www.depositphotos.com https://www.shutterstock.com https://www.eastnews.ru ---------------------------------------------------------------------------------------- For more videos and articles visit: http://www.brightside.me Learn more about your ad choices. Visit megaphone.fm/adchoices

Corran, Batmouse, and special guest Scott make a single definitive list of the top 8 Information Brokers in Star Wars CCG.  Featuring Dan on trivia with help from Greg..This item has files of the following types: Archive BitTorrent, Item Tile, Metadata, PNG, Spectrogram, VBR MP3

Women's History Month: Honoring True Crime Trailblazers March is Women's History Month, and we're spotlighting the female trailblazers who revolutionized true crime. These women—authors, investigators, prosecutors, researchers, and victims' advocates—played pivotal roles in shaping the genre, uncovering the criminal mind, aiding victims, and helping bring criminals to justice. In this episode, we explore the stories of three remarkable women whose work has left a lasting impact on true crime. Join me as we explore the stories of three extraordinary women who left an indelible mark on true crime. You won't want to miss this!

Twitter Saga Continues: Corey once again performs on his Twitter seemingly for us to mock. How many 222s are left this century!? Haunted: Corey's spooky girlfriend Adrien Skye has a recent performance which leads us to find her previous EP, Haunted. On With Mario Lopez: Corey drops by Mario Lopez's drivel of a show which harkens back to the Every Show. Also Flogging Molly Perfect Strangers COREY FELDMAN!, SHOW STOPPER!, LET'S JUST TALK!, DON CHEADLE!, BOOGIE NIGHTS!, REAL ONES!, TIME TRAVEL!, PATREON!, COREY'S TWITTER!, WET OUR BEAKS!, APPETITE!, FIRST SUPER CHAT NAME!, CLETUS VAN DAMME!, JEAN CLAUDE!, FRANK MILITARY!, J PERRY!, GIVING US FODDER!, TOP 10 MOVIES STARRING PEOPLE FROM THE GOONIES!, DUKE GADD!, FENTANYL OVERDOSE!, GUTTURAL DARKNESS!, SCREENRANT!, INDIANA JONES AND THE TEMPLE OF DOOM!, FAIREST WE'VE EVER BEEN!, LUCKY FRITZ!, LICENSE TO KILL!, ROBERT DAVI!, THE MATRIX!, LORD OF THE RINGS TRILOGY!, AVENGERS!, 222 DAY!, DECIPHER!, CENTURY!, ADRIEN SKYE!, ADRIEN CRAIG!, HUNTED!, VAMPIRES BALLAD!, PERFORMANCE!, THE DESCENDANTS!, DISNEY!, CROONING!, LADY BLAHBLAH!, MARIO LOPEZ!, EVERY SHOW!, LASERS!, REGULAR RADIO!, BREAKS!, MARIA MENOUNOS!, ON WITH MARIO LOPEZ!, WILD MAN STEVE!, BIRTHDAYS!, VALENTINE'S DAY!, GUESS!, SIMON PEGG!, GENE HACKMAN!, DEATH!, CAUSE OF DEATH!, TRAIN TO HELL!, DRUGS!, AI!, KISSING!, FRED DURTS!, CAPTAIN AMERICA!, RED HULK!, COMMENT OF THE WEEK!, PERFECT STRANGERS THEME!, AI!, FLOGGING MOLLY!, IRISH PUNK!  You can find the videos from this episode at our Discord RIGHT HERE!

Forecast: Expect increased malicious activity targeting enterprise network infrastructure and remote work platforms. ‍ In this episode of Storm⚡️Watch, the crew tackles some of the most pressing stories in cybersecurity and tech. First, we explore the case of Christian Marie Chapman, an Arizona woman who faces federal prison time for orchestrating a scheme that allowed North Korean IT workers to pose as U.S.-based employees. This operation, which generated over $17 million for North Korea, involved Chapman running a "laptop farm" that enabled remote access to U.S. company networks. The scheme not only compromised sensitive company data but also funneled money to North Korea's weapons programs. This story underscores the critical need for robust identity verification and background checks in hiring processes, especially in remote IT roles, to avoid inadvertently aiding malicious actors. Next, we discuss GreyNoise's findings on the active exploitation of a high-severity vulnerability in Palo Alto Networks PAN-OS (CVE-2025-0108). This authentication bypass flaw allows attackers to execute unauthorized PHP scripts, posing significant risks to unpatched systems. Organizations are urged to apply security patches immediately and restrict access to firewall management interfaces to mitigate potential breaches. GreyNoise's real-time intelligence highlights the importance of staying vigilant against evolving threats. In our featured segment, we sit down with Dennis Fisher, a celebrated journalist with over two decades of experience in cybersecurity reporting. Fisher shares insights from his career, including his work as co-founder of *Threatpost* and Editor-in-Chief at *Decipher*. Known for his analytical approach, Fisher has covered major cybersecurity events and delved into the motivations behind both attackers and defenders. His expertise offers a unique perspective on the complexities of information security. Finally, we touch on broader issues in vulnerability management and encryption policies. From GreyNoise's observations of exploitation surges in vulnerabilities like ThinkPHP and ownCloud to Censys' argument against weakening encryption standards, these discussions emphasize the need for proactive measures and smarter prioritization in cybersecurity strategies. Whether it's patching overlooked vulnerabilities or resisting calls to weaken encryption under the guise of security, staying informed is key to navigating today's threat landscape. Storm Watch Homepage >> Learn more about GreyNoise >>  

Transcript with time code:  https://cuttingedgehealth.com/wp-content/uploads/2025/02/Transcript-47-Dr-Venki-Ramakrishnan.pdf   In this episode, Jane interviews Nobel Prize winner Venki Ramakrishnan, a molecular biologist who offers a balanced perspective on the anti-aging field.   Ramakrishnan discusses various promising areas of anti-aging research, including caloric restriction drugs like rapamycin, senolytics to target senescent cells, and stem cell therapies. He emphasizes the importance of clinical trials and cautions against rushing into unproven treatments. The conversation covers lifestyle factors that can promote healthy aging, such as regular exercise, proper nutrition, and maintaining social connections.   Ramakrishnan shares personal insights, including his father's experience of maintaining an active lifestyle until age 99. He also touches on his own career journey and winning the Nobel Prize. Throughout the interview, he stresses the need for a scientific approach to anti-aging research while acknowledging the urgency felt by many to combat aging. The podcast provides a thoughtful exploration of the current state of anti-aging science, balancing excitement for potential breakthroughs with the need for rigorous scientific validation.   *****   Venki Ramakrishnan shared the 2009 Nobel Prize in Chemistry for uncovering the structure of the ribosome. A National Academy of Sciences member, Venki runs his research group at the MRC Laboratory of Molecular Biology in Cambridge, England. From 2015 to 2020, he served as president of the Royal Society, one of the world's oldest scientific organizations. He is the author of the frank scientific memoir Gene Machine: The Race to Decipher the Secrets of the Ribosome and Amazon bestselling book Why We Die: The New Science of Aging and the Quest for Immortality.   *****   Cutting Edge Health podcast website: https://cuttingedgehealth.com/   Cutting Edge Health Social and YouTube:   YouTube channel: youtube.com/@cuttingedgehealthpodcast   Instagram - https://instagram.com/cuttingedgehealthpodcast   Facebook - https://www.facebook.com/Cutting-Edge-Health-Podcast-with-Jane-Rogers-101036902255756   Please note that the information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Cutting Edge Health podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.   Special thanks to Alan and Maria on the Cutting Edge Health team!    

Welcome to 2025.Remember all the buzz last month about ET disclosure? Those strange ...things....hovering in the skies of New Jersey—lights blinking, colors shifting, orbs appearing and vanishing in plain sight. Large machines, unlike anything we've seen before, flying over military bases.But here's the kicker: the news, social media, and those in charge? They're silent. They claim they don't know what they are.And just like that, the stories vanish. Poof.You'd expect the Open Loops podcast to jump into December's UAP/UFO hype… but we never, ever talk about that… Shhhhhh…So, what do we talk about when we're not talking about...ya know....those.... things...(Shhhhh.....we don't EVER talk about -)We talk about your New Year's resolutions, of course! You know the usual—lose weight, get a promotion, find someone special—but we've got something a little more… out there this year.This year, do you resolve to:-Uncover the lost city of Atlantis—and prove it's still hiding in plain sight, under the waves, with clues embedded in ancient Egyptian architecture?- Track down the 15,000-year-old trident that could rewrite history and prove the existence of an ancient civilization that predates everything we've been taught?- Decipher the forgotten messages of the Anunnaki—and figure out how their genetic engineering of early humans may have shaped your very DNA?-Unlock the mysteries of the 12,000-year-old pyramids and their hidden power, revealing how they might be the secret to humanity's next leap forward?-Solve the riddle of the ancient giants—where did their bones vanish to, and what ancient force was responsible for their disappearance?-Dive into the Sumerian tablets to expose the truth behind their gods and understand what they were really doing when they created mankind?-Investigate the untold stories of the secret space program—is it possible someone has already visited Mars? And what if you could uncover their untold journey?-Reveal the dark truth about humanity's spiritual suppression and uncover how an ancient, suppressed knowledge has been hidden from us to maintain control?-Discover the “sacred secret” buried in the Lost Book of Thoth—a secret so powerful, it could change the course of human evolution and unlock the true potential of your mind?Forgot to add those to the list, didn't you? No worries, Ki'Shara Ninki (Author, Researcher, Hydrid Phenomena Expert and Atlantean Genealogist) has you covered!She returns to enlighten you in this evidence-backed deep dive into our cosmic origins.All your resolutions - resolved. In one podcast episode.And while Greg and Ki'Shara might not talk about these things, unlike the people voted into office in the United States, you might actually hear something of substance...Chapters:(00:00) - Alien Lineage and Psychic Phenomenon(17:18) - Ancient Civilization and Global Connections(31:31) - Collective Religious Storytelling Through History(39:34) - Alien Influence and Human Perspective(41:15) - Gods, Goddesses, and Political Endorsements(50:42) - Anunnaki Heritage and Genetic Manipulation(01:08:30) - Dragons and Genetic Origins(01:13:09) - Dragon Genealogy and Cosmic Ramifications(01:19:37) - Mysterious Mars Trip and Genetic Hybrids(01:32:59) - Exploring Psychic Abilities and Vibrational Frequencies(01:51:45) - Secrets of Earth's Hidden History(02:03:37) - Species and Genetic Evolution(02:12:52) - Celestial Beings and Ancient EnergiesKi'Shara's Links: https://www.afsresearch.org/ Let Greg know how you like the show. Write your review, soliloquy, Haiku or whatever twisted thoughts you want to share at https://ratethispodcast.com/openloops

#STSNation! Welcome to the podcast that promises to bring you the very #BestGuests in all of #TrueCrime. In this special episode of Surviving the Survivor, we delve into the shocking developments in the manhunt for the assassin of CEO Brian Thompson. Investigators have uncovered eerie etchings on bullets and casings, along with disturbing photos of the alleged killer smiling. Deny. Defend. Depose. Joining us tonight are two world-renowned profilers and a retired FBI agent help decode the mindset of this smiling sicko and provide insight into the motives behind the etchings and the attack. #BestGuests: Legendary Profiler Dr. Ann Burgess, Retired FBI Profiler and Agent Gregg McCrary and Retired FBI Agent and Private Investigator Tom Simon (Simon Investigations)Support the show:Patreon: https://www.patreon.com/SurvivingTheSurvivorYouTube: Surviving The Survivor: #BestGuests in True Crime - YouTubeJoel's Book: Https://www.amazon.com/shop/surviving...Website: https://survivingthesurvivor.com#TrueCrime #TrueCrimeCommunity #Manhunt #BrianThompson #CEOMurder #UnitedHealthcare #SmilingSicko #CriminalProfiling #ForensicPsychology #MurderInvestigation #CrimeAnalysis #SurvivingTheSurvivor #truecrimecommunity #truecrimepodcast #truestory #criminaljustice #crimestory #crimenews #criminal #crime_news #newsupdate #breakingnews #nyc #murdernews #murdermystery #wanted #investigations #crime_news

In an age where information is constantly at our fingertips, distinguishing credible news from misleading or false information is more critical than ever. Fake news can distort perspectives, influence decision-making, and undermine trust in legitimate sources. Teaching students how to identify and analyze the credibility of news prepares them to navigate the digital world responsibly and fosters informed citizenship. How We Can Teach Students to Spot Fake News Encourage Critical Thinking Teach students to question the origin of the information, its intent, and its potential biases. Asking "Who wrote this?" and "Why was it written?" helps develop a skeptical mindset. Introduce Fact-Checking Tools You can familiarize students with tools like Snopes, FactCheck.org, or basic search techniques to cross-check information from multiple reputable sources. Spot Emotional Language Teach students to recognize when an article uses overly emotional or sensational language, which can indicate bias or an intent to mislead. Evaluate Sources Help students learn to identify credible sources, including checking the publication's history, credentials, and editorial standards. Practice With Real-Life Scenarios Provide students with examples of true and false stories and work through identifying characteristics that distinguish one another. Our guest in Episode 274 of Class Dismissed is David Cutler, a Massachusetts high school history and journalism teacher. Cutler recognizes the importance of teaching to distinguish between legitimate news sources and news sites designed strictly for political or monetary gain. Cutler authored a column featured on PBS Newshour titled “How I use George Washington to make kids care about fake news.” He detailed his methods in Episode 274. Listen to this latest episode on your favorite podcast app or Apple Podcast

The following question refers to Sections 7.3.3 and 7.3.6 of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure.The question is asked by Palisades Medical Center medicine resident & CardioNerds Academy Fellow Dr. Maryam Barkhordarian, answered first by UTSW AHFT Cardiologist & CardioNerds FIT Ambassador Dr. Natalie Tapaskar, and then by expert faculty Dr. Robert Mentz.Dr. Mentz is associate professor of medicine and section chief for Heart Failure at Duke University, a clinical researcher at the Duke Clinical Research Institute, and editor-in-chief of the Journal of Cardiac Failure. Dr. Mentz has been a mentor for the CardioNerds Clinical Trials Network as lead principal investigator for PARAGLIDE-HF and is a series mentor for this very Decipher the Guidelines Series. For these reasons and many more, he was awarded the Master CardioNerd Award during ACC22.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. American Heart Association's Scientific Sessions 2024As heard in this episode, the American Heart Association's Scientific Sessions 2024 is coming up November 16-18 in Chicago, Illinois at McCormick Place Convention Center. Come a day early for Pre-Sessions Symposia, Early Career content, QCOR programming and the International Symposium on November 15. It's a special year you won't want to miss for the premier event for advancements in cardiovascular science and medicine as AHA celebrates its 100th birthday. Registration is now open, secure your spot here!When registering, use code NERDS and if you're among the first 20 to sign up, you'll receive a free 1-year AHA Professional Membership! Question #39 Ms. Kay Lotsa is a 48-year-old woman with a history of CKD stage 2 (baseline creatinine ~1.2 mg/dL) & type 2 diabetes mellitus. She has recently noticed progressively reduced exercise tolerance, leg swelling, and trouble lying flat. This prompted a hospital admission with a new diagnosis of decompensated heart failure. A transthoracic echocardiogram reveals LVEF of 35%. Ms. Lotsa is diuresed to euvolemia, and she is started on carvedilol 25mg BID, sacubitril/valsartan 49-51mg BID, and empagliflozin 10mg daily, which she tolerates well. Her eGFR is at her baseline of 55 mL/min/1.73 m2 and serum potassium concentration is 3.9 mEq/L. Your team is anticipating she will be discharged home in the next one to two days and wants to start spironolactone. Which of the following is most important regarding her treatment with mineralocorticoid antagonists?ASpironolactone is contraindicated based on her level of renal impairment and should not be startedBSerum potassium levels and kidney function should be assessed within 1-2 weeks of starting spironolactoneCEplerenone confers a higher risk of gynecomastia than does spironolactoneDThe patient will likely not benefit from initiation of spironolactone if her cardiomyopathy is ischemic in origin Answer #39 ExplanationThe correct answer is B – after starting a mineralocorticoid receptor antagonist (MRA), it is important to closely monitor renal function and serum potassium levels.MRA (also known as aldosterone antagonists or anti-mineralocorticoids) show consistent improvements in all-cause mortality, HF hospitalizations, and SCD across a wide range of patients with HFrEF.

The following question refers to Sections 7.4 and 7.5 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by the Director of the CardioNerds Internship Dr. Akiva Rosenzveig, answered first by Vanderbilt AHFT cardiology fellow Dr. Jenna Skowronski, and then by expert faculty Dr. Randall Starling.Dr. Starling is Professor of Medicine and an advanced heart failure and transplant cardiologist at the Cleveland Clinic where he was formerly the Section Head of Heart Failure, Vice Chairman of Cardiovascular Medicine, and member of the Cleveland Clinic Board of Governors. Dr. Starling is also Past President of the Heart Failure Society of America in 2018-2019. Dr. Staring was among the earliest CardioNerds faculty guests and has since been a valuable source of mentorship and inspiration. Dr. Starling's sponsorship and support was instrumental in the origins of the CardioNerds Clinical Trials Program.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. American Heart Association's Scientific Sessions 2024As heard in this episode, the American Heart Association's Scientific Sessions 2024 is coming up November 16-18 in Chicago, Illinois at McCormick Place Convention Center. Come a day early for Pre-Sessions Symposia, Early Career content, QCOR programming and the International Symposium on November 15. It's a special year you won't want to miss for the premier event for advancements in cardiovascular science and medicine as AHA celebrates its 100th birthday. Registration is now open, secure your spot here!When registering, use code NERDS and if you're among the first 20 to sign up, you'll receive a free 1-year AHA Professional Membership! Question #38 Mrs. M is a 65-year-old woman with non-ischemic dilated cardiomyopathy (LVEF 40%) and moderate to severe mitral regurgitation (MR) presenting for outpatient follow-up. Despite improvement overall, she continues to experience dyspnea on exertion with two flights of stairs and occasional PND. She reports adherence with her medication regimen of sacubitril-valsartan 97-103mg twice daily, metoprolol succinate 200mg daily, spironolactone 25mg daily, empagliflozin 10mg daily, and furosemide 80mg daily. A transthoracic echocardiogram today shows an LVEF of 35%, an LVESD of 60 mm, severe MR with a regurgitant fraction of 60%, and an estimated right ventricular systolic pressure of 40 mmHg. Her EKG shows normal sinus rhythm at 65 bpm and a QRS complex width of 100 ms. What is the most appropriate recommendation for management of her heart failure?AContinue maximally tolerated GDMT; no other changesBRefer for cardiac resynchronization therapy (CRT)CRefer for transcatheter mitral valve intervention Answer #38 ExplanationChoice C is correct. The 2020 ACC/AHA Guidelines for the management of patients with valvular heart disease outline specific recommendations.In patients with chronic severe secondary MR related to LV systolic dysfunction (LVEF

The following question refers to Section 7.4 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by the Director of the CardioNerds Internship Dr. Akiva Rosenzveig, answered first by Vanderbilt AHFT cardiology fellow Dr. Jenna Skowronski, and then by expert faculty Dr. Clyde Yancy.Dr. Yancy is Professor of Medicine and Medical Social Sciences, Chief of Cardiology, and Vice Dean for Diversity and Inclusion at Northwestern University, and a member of the ACC/AHA Joint Committee on Clinical Practice Guidelines.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. American Heart Association's Scientific Sessions 2024As heard in this episode, the American Heart Association's Scientific Sessions 2024 is coming up November 16-18 in Chicago, Illinois at McCormick Place Convention Center. Come a day early for Pre-Sessions Symposia, Early Career content, QCOR programming and the International Symposium on November 15. It's a special year you won't want to miss for the premier event for advancements in cardiovascular science and medicine as AHA celebrates its 100th birthday. Registration is now open, secure your spot here!When registering, use code NERDS and if you're among the first 20 to sign up, you'll receive a free 1-year AHA Professional Membership! Question #37 Mr. S is an 80-year-old man with a history of hypertension, type II diabetes mellitus, and hypothyroidism who had an anterior myocardial infarction (MI) treated with a drug-eluting stent to the left anterior descending artery (LAD) 45 days ago. His course was complicated by a new LVEF reduction to 30%, and left bundle branch block (LBBB) with QRS duration of 152 ms in normal sinus rhythm. He reports he is feeling well and is able to enjoy gardening without symptoms, though he experiences dyspnea while walking to his bedroom on the second floor of his house. Repeat TTE shows persistent LVEF of 30% despite initiation of goal-directed medical therapy (GDMT). What is the best next step in his management?AMonitor for LVEF improvement for a total of 60 days prior to further interventionBImplantation of a dual-chamber ICDCImplantation of a CRT-DDContinue current management as device implantation is contraindicated given his advanced age Answer #37 Explanation Choice C is correct. Implantation of a CRT-D is the best next step. In patients with nonischemic DCM or ischemic heart disease at least 40 days post-MI with LVEF ≤35% and NYHA class II or III symptoms on chronic GDMT, who have reasonable expectation of meaningful survival for >1 year,ICD therapy is recommended for primary prevention of SCD to reduce total mortality (Class 1, LOE A). A transvenous ICD provides high economic value in this setting, particularly when a patient's risk of death from ventricular arrhythmia is deemed high and the risk of nonarrhythmic death is deemed low. In addition, for patients who have LVEF ≤35%, sinus rhythm, left bundle branch block (LBBB) with a QRS duration ≥150 ms, and NYHA class II, III, orambulatory IV symptoms on GDMT, cardiac resynchronization therapy (CRT) is indicated to reduce total mortality, reduce hospitalizations, and improve symptoms and QOL. Cardiac resynchronization provides high economic value in this setting. Mr.

The following question refers to Sections 2.1 and 4.2 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by CardioNerds Academy Intern Dr. Adriana Mares, answered first by CardioNerds FIT Trialist Dr. Christabel Nyange, and then by expert faculty Dr. Shelley Zieroth. Dr. Zieroth is an advanced heart failure and transplant cardiologist, Head of the Medical Heart Failure Program, the Winnipeg Regional Health Authority Cardiac Sciences Program, and an Associate Professor in the Section of Cardiology at the University of Manitoba. Dr. Zieroth is a past president of the Canadian Heart Failure Society. She has been a PI Mentor for the CardioNerds Clinical Trials Program. The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. American Heart Association's Scientific Sessions 2024As heard in this episode, the American Heart Association's Scientific Sessions 2024 is coming up November 16-18 in Chicago, Illinois at McCormick Place Convention Center. Come a day early for Pre-Sessions Symposia, Early Career content, QCOR programming and the International Symposium on November 15. It's a special year you won't want to miss for the premier event for advancements in cardiovascular science and medicine as AHA celebrates its 100th birthday. Registration is now open, secure your spot here!When registering, use code NERDS and if you're among the first 20 to sign up, you'll receive a free 1-year AHA Professional Membership! Question #36 A 50-year-old woman presents to establish care. Her medical history includes COPD, prediabetes, and hypertension. She is being treated with chlorthalidone, amlodipine, lisinopril, and a tiotropium inhaler. She denies chest pain, dyspnea on exertion, or lower extremity edema. On physical exam, blood pressure is 154/88 mmHg, heart rate is 90 beats/min, and respiration rate is 22 breaths/min with an oxygen saturation of 94% breathing ambient room air. BMI is 36 kg/m2. Jugular venous pulsations are difficult to assess due to her body habitus. Breath sounds are distant, with occasional end-expiratory wheezing. Heart sounds are distant, and extra sounds or murmurs are not detected. Extremities are warm and without peripheral edema. B-type natriuretic peptide level is 28 pg/mL (28 ng/L). A chest radiograph shows increased radiolucency of the lungs, flattened diaphragms, and a narrow heart shadow consistent with COPD. An electrocardiogram shows evidence of left ventricular hypertrophy. The echocardiogram showed normal LV and RV function with no significant valvular abnormalities. In which stage of HF would this patient be classified?AStage A: At Risk for HFBStage B: Pre-HFCStage C: Symptomatic HFDStage D: Advanced HF  Answer #36 Explanation The correct answer is A – Stage A or at risk for HF. This asymptomatic patient with no evidence of structural heart disease or positive cardiac biomarkers for stretch or injury would be classified as Stage A or “at risk” for HF. The ACC/AHA stages of HF emphasize the development and progression of disease with specific therapeutic interventions at each stage. Advanced stages and disease progression are associated with reduced survival. The stages were revised in this edition of guidelines to emphasize new terminologies of “at risk” for Stage A and “pre...

#STSNation, Welcome to Surviving The Survivor the podcast that brings you the best guests in true crime.  Lyle and Erik Menendez were convicted of the grisly 1989 shotgun murders of their parents, Jose and Mary Louise "Kitty" Menendez, at the family's sprawling Beverly Hills mansion. They've been in prison ever since. But, do they have a new shot at freedom? A major press conference is set for Wednesday October 16th about resentencing the brothers. #BestGuests: Dr. Ann Burgess is an internationally recognized pioneer in the assessment and treatment of victims of trauma and abuse, and author of A Killer by Design: Murderers, Mindhunters, and My Quest to Decipher the Criminal Mind. Among her many awards and accolades, in 2016 she was named a Living Legend by the American Academy of Nursing She has also worked with FBI Academy special agents to study serial offenders, and the links between child abuse, juvenile delinquency, and subsequent perpetration. Erlinda Ocampo Johnson Erlinda Ocampo Johnson, University of New Mexico School of Law graduate ('95), was appointed the special prosecutor in the Alec Baldwin case. She's a highly experienced and successful Criminal Defense and Personal Injury Attorney that has represented hundreds of clients facing Federal and State Criminal Charges R. Timothy Jansen has handled complex Civil, Administrative and Criminal Litigation s, first as Chief Trial Counsel for the Secretary of State of Florida, Tallahassee, handling both complex Civil and Criminal matters. Afterwards, he worked as a Senior Fraud Prosecutor for the United States Attorney in Tampa, handling exclusively complex White Collar Crimes, including Health Care Fraud Litigation. He was also the Chairmain of the Health Care Fraud Task Force and a member of the Attorney General's Health Care Fraud Task Force in Washington, D.C. Mr. Jansen also practices in the areas of Constitutional (First Amendment)  Support the show:Patreon: https://www.patreon.com/SurvivingTheSurvivorYouTube: Surviving The Survivor: #BestGuests in True Crime - YouTubeJoel's Book: Https://www.amazon.com/shop/surviving...Website: https://survivingthesurvivor.comAll Things STS: https://linktr.ee/stspodcast #MenendezBrothers #TrueCrime #LyleMenendez #ErikMenendez #Menudo #BoyBand #PrisonLife #TrueCrimeCommunity #DomesticViolence #LosAngeles #GeorgeGascon #DistrictAttorney #truecrimecommunity #truecrimepodcast #truestory #justice #criminaljustice #crimestory #breakingnews #newsupdate

Kelly Hooker joins me for the October's Real Time Reading episode where we highlight our current, past and upcoming reads. Kelly's Selections: Last:  Broken Country by Clare Leslie Hall Famous Last Words by Gillian McAllister Now: Jane and Dan at the End of the World by Colleen Oakley  The Small and the Mighty by Sharon McMahon Next: The Family Inside by Katie Garner One Good Thing by Georgia Hunter DNFs or Didn't Like: Isola by Allagra Goodman  Clever Little Thing by Helena Eschlin Book Mail Highlights: The Trouble Up North by Travis Mulhauser  The Snowbirds by Christina Clancey   Cindy's Selections: Last: We Solve Murders by Richard Osman Rental House by Weike Wang Now: Eden Undone by Abbott Kahler  The Oligarch's Daughter by Joseph Finder Next: Everyone This Christmas Has a Secret by Benjamin Stevenson Kills Well with Others by Deanna Raybourn  DNFs or Didn't Like: The Way by Cary Groner  The Mesmerist by Caroline Wood Book Mail Highlights:  Jane and Dan at the End of the World by Colleen Oakley  The Mesopotamian Riddle: An Archaeologist, a Soldier, a Clergyman, and the Race to Decipher the World's Oldest Writing by Joshua Hammer  Literary Lookbook information: Want to know which new titles are publishing in May - October of 2024? Check out our second Literary Lookbook which contains a comprehensive but not exhaustive list all in one place so you can plan ahead.  Our third Literary Lookbook will be out at the end of October. Join my Patreon group to support the podcast.  Other ways to support the podcast can be found here.     Connect with Kelly Hooker on Instagram. Connect with me on Instagram, Facebook, YouTube, and Threads.  Learn more about your ad choices. Visit megaphone.fm/adchoices

#STSNation, Welcome to another episode of Surviving The Survivor, the podcast that brings you the #BestGuests in all of True Crime… Among 120 civil lawsuits expected to be filed against Sean 'P. Diddy' Combs is one involving a nine-year-old, according to a Texas lawyer who is overseeing the reported cases. Attorney Tony Buzbee alleged during a press conference: "This, individual who was nine years old at the time, was taken to an audition in New York City with Bad Boy Records. Other boys were there to audition as well. All of them were trying to land a record deal. All of them were minors. This individual was sexually abused, allegedly, by Sean Combs, and several other people at the studio in the promise to both his parents and to him himself of getting a record deal." #BestGuests: Dr. Ann Burgess is an internationally recognized pioneer in the assessment and treatment of victims of trauma and abuse, and author of A Killer by Design: Murderers, Mindhunters, and My Quest to Decipher the Criminal Mind. Among her many awards and accolades, in 2016 she was named a Living Legend by the American Academy of Nursing She has also worked with FBI Academy special agents to study serial offenders, and the links between child abuse, juvenile delinquency, and subsequent perpetration. Dr. Anna Salter is an American psychologist, an internationally recognized expert on sexual predators, and a mystery novelist. Dr. Salter earned her MA from Tufts University and PhD from Harvard University. She has been a teaching fellow at both Tufts University and Harvard University. She is the author of several non-fiction books including Predators: Pedophiles, Rapists, and Other Sex Offenders: Who They Are, How They Operate, and How We Can Protect Our Children (2003), and Treating Child Sex Offenders and Victims (1988) Robert Prentky has practiced as a forensic psychologist for the past 35+ years, and in that capacity assessed or supervised the assessment of 2,000+ offenders in 30-40 prisons around the country. He's been conducting research on sexual offenders for the past 38 years, with support from 20 state and federal research grants.   Support the show:Patreon: https://www.patreon.com/SurvivingTheSurvivorYouTube: Surviving The Survivor: #BestGuests in True Crime - YouTubeJoel's Book: Https://www.amazon.com/shop/surviving...Website: https://survivingthesurvivor.comAll Things STS: https://linktr.ee/stspodcast #Diddy #FreakOff #SeanCombs #Cassie #TrueCrime #Rap #RapGame #CassieVentura #TrueCrime #TrueCrimeCommunity #Rapper #ThugLife

The following question refers to Section 2.2 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.The question is asked by University of Colorado internal medicine resident Dr. Hirsh Elhence, answered first by University of Chicago advanced heart failure cardiologist and Co-Chair for the CardioNerds Critical Care Cardiology Series Dr. Mark Belkin, and then by expert faculty Dr. Mark Drazner.Dr. Drazner is an advanced heart failure and transplant cardiologist, Professor of Medicine, and Clinical Chief of Cardiology at UT Southwestern. He is the President of the Heart Failure Society of America.The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance.Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values.  Question #35 A 50-year-old woman with a history of congestive heart failure, hypertension, type 2 diabetes mellitus, and obstructive sleep apnea presents to the outpatient clinic to follow up on her heart failure management. One year prior, echocardiogram showed an ejection fraction of 30% with an elevated BNP, for which she was started on appropriate GDMT. Repeat echocardiogram today showed an EF of 50%. Which of the following best describes her heart failure status? A HFrEF (HF with reduced EF) B HFimpEF (HF with improved EF) C HFmrEF (HF with mildly reduced EF) D HFpEF (HF with preserved EF) Answer #35 Explanation The correct answer is B – HFimpEF, or heart failure with improved ejection fraction, best describes her current heart failure status. Left ventricular ejection fraction is an important factor in classifying heart failure given differences in prognosis, response to treatment, and use in clinical trial enrollment criteria. The classification of heart failure by EF (adopted from the Universal Definition of HF): –        HFrEF (HF with reduced EF): LVEF ≤40% –        HFimpEF (HF with improved EF): previous LVEF ≤40%, a ≥10% increase from baseline LVEF, and a second measurement of LVEF >40%. –        HFmrEF (HF with mildly reduced EF): LVEF 41%–49%, andevidence of spontaneous or provokable increased LV filling pressures (e.g., elevated natriuretic peptide, noninvasive and invasive hemodynamic measurement) –        HFpEF (HF with preserved EF): LVEF ≥50%, and evidence of spontaneous or provokable increased LV filling pressures (e.g., elevated natriuretic peptide, noninvasive and invasive hemodynamic measurement) Patients with HFmrEF are usually in a dynamic state of improving from HFrEF or deteriorating towards HFrEF. Therefore, patients with HFmrEF may benefit from follow-up evaluation of systolic function and etiology of sub-normal EF. Improvements in EF are associated with better outcomes but do not indicate full myocardial recovery or normalization of LV function. Indeed, structural and functional abnormalities such as LV dilation and systolic or diastolic dysfunction often persist. Moreover, EF may remain dynamic with fluctuations in either direction depending on factors such as GDMT adherence and re-exposure to cardiotoxic agents. As such, the term heart failure with “improved EF” was deliberately chosen over “recovered EF” and “preserved EF”. Importantly, in patients with HFimpEF while on GDMT, the EF may decrease after withdrawal of GDMT. Main Takeaway

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Ted Schaeffer is an internationally recognized urologist specializing in prostate cancer and a returning guest on The Drive. In this episode, Ted provides insights into the role testosterone plays, or doesn't play, in the initiation and progression of prostate cancer. He unpacks the findings and limitations of the recent TRAVERSE trial, exploring the complex relationship between testosterone and prostate cancer. Ted delves into the molecular nature of prostate cancer, explaining the androgen receptor saturation theory and the potential impact of testosterone on cancer growth. He also discusses the use of the Decipher test to predict cancer aggressiveness and guide targeted treatment. Furthermore, Ted shares how he counsels patients regarding testosterone replacement therapy (TRT), including its safe administration in patients with low-grade prostate cancer. Additionally, he highlights advancements in prostate cancer therapies and biomarkers that help develop precise treatment strategies while minimizing the need for broad androgen deprivation therapy. We discuss: Background on the TRAVERSE trial: insights into exogenous testosterone and prostate cancer risk [3:00]; The androgen receptor saturation theory: how different organs respond to varying levels of testosterone [10:30]; The relationship between testosterone levels and prostate cancer aggressiveness: how aggressive prostate tumors have lower androgen receptor activity and rely on different growth mechanisms [16:15]; Using the Decipher score to assess prostate cancer aggressiveness and guide personalized treatment strategies [23:45]; Considerations for testosterone replacement therapy: how Ted counsels patients, how TRT can be safely administered in patients with low-grade prostate cancer, and more [31:15]; Advancements in prostate cancer therapies and PSA as a biomarker for precise treatment decisions, minimizing the need for broad androgen deprivation therapy [38:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube